LOS ANGELES, CA--(Marketwire - January 09, 2009) - Universal Detection Technology (www.udetection.com) (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that through its deal with US Department of Commerce’s Commercial Service, it is promoting the Company’s handheld assays, used for detection of up to five bioterrorism agents. UNDT is listed as a Featured US Exporter on Commercial Service’s Kuwait website. UNDT’s 5-agent bioterrorism detection kits have been extensively used by first responders and private industry throughout the United States. Testing of the kits by the US DOD as well as the United Kingdom military shows that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered “white powders.” The kits are designed to test for anthrax, botulinum toxin, Ricin, plague (Y. Pestis) and SEBs in as little as 3 minutes.
Since the Jihad against the Soviet Union in Afghanistan, Kuwait has had no shortage of militants willing to undertake violent acts in the name of Islam. A small minority of Kuwaitis has consistently demonstrated the intent to engage in Islamic militancy. Kuwait, on the other hand, plays a significant role in the multinational effort to stabilize Iraq and to protect the Persian Gulf.
“We are pleased to make our equipment available on the Kuwait website of the US Commercial Service,” said Mr. Jacques Tizabi, UNDT’s Chairman and CEO.
To view UNDT’s handheld assays on the website of the Commercial Service in the UAE please go to: http://www.buyusa.gov/kuwait/en/american_brands.html?exp_cat=6010&exp_pid=79.
For more information please visit our website at www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company’s actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.
Contact:
Jacques Tizabi
310-248-3655
Email Contact
